Psychotropic prescription patterns among patients diagnosed with depressive disorder based on claims database in Japan

Clinical Drug Investigation

Volumn 33, Issue 8, 2013, Pages 597-605

  Onishi, Yoshie ^a   Hinotsu, Shiro ^a   Furukawa, Toshiaki A ^a   Kawakami, Koji ^a  

^a KYOTO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; BENZODIAZEPINE DERIVATIVE; NEUROLEPTIC AGENT; PSYCHOTROPIC AGENT; SULPIRIDE;

ADULT; AGED; ANXIETY DISORDER; ARTICLE; COHORT ANALYSIS; DYSTHYMIA; FEMALE; HOSPITALIZATION; HUMAN; INSURANCE; JAPAN; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; MONOTHERAPY; OBSERVATIONAL STUDY; POLYPHARMACY; PRESCRIPTION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; TREATMENT DURATION;

ADULT; ANTIDEPRESSIVE AGENTS; DEPRESSION; FEMALE; HUMANS; INSURANCE CLAIM REVIEW; JAPAN; MALE; MIDDLE AGED; PHYSICIAN'S PRACTICE PATTERNS; RETROSPECTIVE STUDIES;

EID: 84880912344     PISSN: 11732563     EISSN: 11791918     Source Type: Journal    
DOI: 10.1007/s40261-013-0104-y     Document Type: Article

References (31)

1. Ministry of Health, Labor and Welfare, Tokyo, Japan. Patient survey 2008. Tokyo: Ministry of Health, Labor and Welfare; 2008.
2. Furukawa TA, Akechi T, Shimodera S, et al. Strategic use of new generation antidepressants for depression: SUND study protocol. Trials. 2011;11(12):116.
3. Motohashi N, editor. Pharmacotherapy algorithms for mood disorders. Tokyo: Jihou; 2003.
4. National Collaborating Centre for Mental Health (UK). Depression: the treatment and management of depression in adults (updated edition). Leicester: British Psychological Society; 2010. NICE Clinical Guidelines, no. 90.
5. Lam RW, Kennedy SH, Grigoriadis S, The Canadian Network for Mood and Anxiety Treatments (CANMAT), et al. Canadian Network for Mood and Anxiety Treatments (CANMAT) clinical guidelines for the management of major depressive disorder in adults. III. Pharmacotherapy. J Affect Disord. 2009;117(Suppl 1):S26-43.
6. Texas Department of State Health Services. Texas medication algorithm project procedural manual: major depressive disorder algorithms, USA. 2008 http://www.pbhcare.org/pubdocs/upload/documents/TMAP%20Depression%202010.pdf. Accessed 12 Jan 2013.
7. Treatment guideline II: major depressive disorder, 2012, ver. 1. Tokyo: The Japanese Society of Mood Disorders (JSMD); 2012.
8. Sawada N, Uchida H, Suzuki T, et al. Persistence and compliance to antidepressant treatment in patients with depression: a chart review. BMC Psychiatry. 2009;16(9):38.
9. Uchida N, Chong MY, Tan CH, et al. International study on antidepressant prescription pattern at 20 teaching hospitals and major psychiatric institutions in East Asia: analysis of 1,898 cases from China, Japan, Korea, Singapore and Taiwan. Psychiatry Clin Neurosci. 2007;61(5):522-8.
10. National Health Insurance (NHI) price dictionary, 2012 April version. Tokyo: Jiho; 2012.
11. Ueshima K, Higuchi T, Kanba S, et al. Views on drug therapy for depression: proposals based on the field survey [in Japanese]. Jpn Med J. 2005;4262:18-62.
12. Inagaki A. Prescription patterns of antidepressant. Health and labour sciences research 2002 [in Japanese]. http://www.ncnp.go.jp/tmc/pdf/22-report03. pdf. Accessed 20 Jan 2013.
13. Ray WA. Evaluating medication effects outside of clinical trials: new-user designs. Am J Epidemiol. 2003;158(9):915-20.
14. Japan Medical Data Center Co. Ltd. Tokyo, Japan [in Japanese]. http://www.jmdc.co.jp/en/srv-pharma/jdm.html. Accessed 21 Jan 2013.
15. Kimura S, Sato T, Ikeda S, et al. Development of a database of health insurance claims: standardization of disease classifications and anonymous record linkage. J Epidemiol. 2010;20(5):413-9.
16. International Classification of Disease, 10th revision (ICD-10) diagnosis codes, vol. 2. Geneva: World Health Organization; 2004.
17. Master of diseases and injuries names version 3 [in Japanese]. Tokyo: Medical Information System Development Center (MEDIS-DC); 2011.
18. Davidson JR. Major depressive disorder treatment guidelines in America and Europe. J Clin Psychiatry. 2010;71(Suppl E1):e04.
19. Furukawa TA, Streiner DL, Young LT. Antidepressant and benzodiazepine for major depression. Cochrane Database Syst Rev. 2002;(1):CD001026.
20. Pfeiffer P, Ganoczy D, Zivin K, et al. Benzodiazepines and adequacy of initial antidepressant treatment for depression. Clin Psychopharmacol. 2011;31(3):360-4.
21. Lai IC, Wang MT, Wu BJ, et al. The use of benzodiazepine monotherapy for major depression before and after implementation of guidelines for benzodiazepine use. J Clin Pharm Ther. 2011;36(5):577-84.
22. Lader MH, Petursson H. Benzodiazepine derivatives - side effects and dangers. Biol Psychiatry. 1981;16:1195-201.
23. Pecknold JC. Discontinuation reaction to alprazolam in panic disorder. J.Psychiatr. Res. 1993;27(Suppl. 1):155-70.
24. Richels K, Case WG, Dowing RW, et al. Long-term diazepam therapy and clinical outcome. JAMA. 1983;250:767-71.
25. Maeda H, Egami H, Tomita M, et al. How does sulpiride work and how is it utilized? Jpn J Clin Psychopharmacol. 2007;10(10):1853-60.
26. Hasin DS, Goodwin RD, Stinson FS, et al. Epidemiology of major depressive disorder: results from the National Epidemiologic Survey on alcoholism and related conditions. Arch Gen Psychiatry. 2005;62(10):1097-106.
27. Kessler RC, Berglund P, Demler O, et al. The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R). JAMA. 2003;289(23):3095-105.
28. Felker BL, Hedrick SC, Chaney EF, et al. Identifying depressed patients with a high risk of comorbid anxiety in primary care. Prim Care Companion J Clin Psychiatry. 2003;5(3):104-10.
29. Clayton PJ, Grove WM, Coryell W, et al. Follow-up and family study of anxious depression. Am J Psychiatry. 1991;148(11):1512-7.
30. Wu CH, Erickson SR, Piette JD, et al. The association of race, comorbid anxiety, and antidepressant adherence among Medicaid enrollees with major depressive disorder. Res Social Adm Pharm. 2012;8(3):193-205.
31. Morehouse R, Macqueen G, Kennedy SH. Barriers to achieving treatment goals: a focus on sleep disturbance and sexual dysfunction. J Affect Disord. 2011;132(Suppl 1):S14-20.